Oncotarget. 2017 Jul 26;8(35):59748-59756. doi: 10.18632/oncotarget.19574. eCollection 2017 Aug 29.
The response of the Oxford classification to steroid in IgA nephropathy: a systematic review and meta-analysis.
Oncotarget
Pingping Yang, Xi Chen, Lei Zeng, Hua Hao, Gaosi Xu
Affiliations
Affiliations
- Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
- Grade 2013, The Second Clinical Medical College of Nanchang University, Nanchang, China.
- Department of Pathology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
PMID: 28938678
PMCID: PMC5601774 DOI: 10.18632/oncotarget.19574
Abstract
BACKGROUND: The present review is aimed to evaluate the correlation between pathological features and the response to steroid in the patients with IgA nephropathy according to the Oxford classification, mesangial hypercellularity (M), endocapillary hypercellularity (E), segmental glomerulosclerosis (S), tubular atrophy and interstitial fibrosis (T).
METHODS: We searched Chinese Biomedical Database, EMBASE, Cochrane Library, PubMed and MEDLINE with all spellings of "IgA nephropathy", "Oxford Classification", and "steroid".
RESULTS: 5 studies with 637 patients were eligible for inclusion. The analysis showed that M1, S1, and T1/2 was strongly associated with the prediction to steroid resistance when compared with M0 [odds ratio (OR) 1.89, 95% confidence interval (
CONCLUSION: IgA nephropathy patients with serious pathological changes (M1, S1, and T1/2) were more resistant to steroid than slight ones (M0, S0, and T0), and E1 is better response to steroid therapy than T1/2.
Keywords: IgA nephropathy; Oxford classification; proteinuria; steroid
Conflict of interest statement
CONFLICTS OF INTEREST The authors have declared that there is no competing interest.
References
- Am J Kidney Dis. 1991 Jul;18(1):12-9 - PubMed
- Kidney Int. 2012 Oct;82(8):840-56 - PubMed
- Nihon Jinzo Gakkai Shi. 1988 Mar;30(3):247-51 - PubMed
- Curr Opin Nephrol Hypertens. 2009 May;18(3):212-9 - PubMed
- J Nephrol. 2016 Jun;29(3):367-375 - PubMed
- Clin J Am Soc Nephrol. 2011 Sep;6(9):2175-84 - PubMed
- Nephrol Dial Transplant. 2005 Feb;20(2):342-8 - PubMed
- Am J Kidney Dis. 2013 Nov;62(5):891-9 - PubMed
- Chin Med J (Engl). 2002 Sep;115(9):1301-7 - PubMed
- J Am Soc Nephrol. 2017 Feb;28(2):691-701 - PubMed
- Kidney Int. 2009 Sep;76(5):534-45 - PubMed
- Oncotarget. 2016 Jun 7;7(23):33616-26 - PubMed
- N Engl J Med. 2013 Jun 20;368(25):2402-14 - PubMed
- Int Urol Nephrol. 2012 Aug;44(4):1177-84 - PubMed
- J Am Soc Nephrol. 2015 Sep;26(9):2248-58 - PubMed
- Clin Nephrol. 1986 Oct;26(4):174-80 - PubMed
- J Nephrol. 2005 Sep-Oct;18(5):503-12 - PubMed
- Clin Nephrol. 2009 Jun;71(6):625-31 - PubMed
- J Korean Med Sci. 2009 Jan;24 Suppl:S44-9 - PubMed
- Ann Intern Med. 2009 Aug 18;151(4):W65-94 - PubMed
- Pediatr Nephrol. 2015 Jul;30(7):1121-9 - PubMed
- Kidney Int. 2014 Oct;86(4):828-36 - PubMed
- Am J Kidney Dis. 2000 Aug;36(2):227-37 - PubMed
- Kidney Int. 2017 May;91(5):1014-1021 - PubMed
- Am J Kidney Dis. 2007 Jun;49(6):763-75 - PubMed
- Clin Exp Nephrol. 2016 Apr;20(2):244-52 - PubMed
- Intern Med. 2015;54(17):2207-11 - PubMed
- Q J Med. 1985 Oct;57(222):677-88 - PubMed
Publication Types